SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment...
SONOSCAPE released its performance for the first three quarters, with a net profit attributable to the parent company of 33.5111 million yuan, a decrease of 69.25%
SONOSCAPE Supervisory Board approves adjustments and grant proposals related to the incentive plan
SONOSCAPE and Batai Medical officially reached a strategic cooperation
The A-share medical device sector fluctuated and rose, with Allgens and United Imaging Healthcare increasing by over 10%. SONOSCAPE, MGI, Double Medical, Tinavi, and Mindray also followed suit
SONOSCAPE plans to grant 1.914 million restricted shares and 3.9678 million stock options
SONOSCAPE: Net profit begins to be released quarter by quarter, expected performance will gradually emerge from the trough period